Differences in Daily Physical Activity by Alzheimer's Risk Markers Among Older Adults

• Published in: The journals of gerontology. Series A, Biological sciences and medical sciences Biological sciences and medical sciences, 2024-07, Vol.79 (7)
• Main Authors: Marino, Francesca R, Deal, Jennifer A, Dougherty, Ryan J, Bilgel, Murat, Tian, Qu, An, Yang, Simonsick, Eleanor M, Resnick, Susan M, Ferrucci, Luigi, Spira, Adam P, Wanigatunga, Amal A, Schrack, Jennifer A
• Format: Article
• Language: English
• Subjects: Accelerometry; Aged; Aged, 80 and over; Alzheimer Disease - genetics; Alzheimer Disease - physiopathology; Amyloid beta-Peptides - metabolism; Apolipoprotein E4 - genetics; Baltimore; Biomarkers; Cross-Sectional Studies; Exercise - physiology; Female; Genotype; Humans; Longitudinal Studies; Male; Risk Factors
• ISSN: 1079-5006; 1758-535X; 1758-535X
• DOI: 10.1093/gerona/glae119

Daily physical activity patterns differ by Alzheimer's disease (AD) status and might signal cognitive risk. It is critical to understand whether patterns are disrupted early in the AD pathological process. Yet, whether established AD risk markers (β-amyloid [Aβ] or apolipoprotein E-ε4 [APOE-ε4]) are associated with differences in objectively measured activity patterns among cognitively unimpaired older adults is unclear. Wrist accelerometry, brain Aβ (+/-), and APOE-ε4 genotype were collected in 106 (Aβ) and 472 (APOE-ε4) participants (mean age 76 [standard deviation{SD}: 8.5) or 75 [SD: 9.2] years, 60% or 58% women) in the Baltimore Longitudinal Study of Aging. Adjusted linear and function-on-scalar regression models examined whether Aβ or APOE-ε4 status was cross-sectionally associated with activity patterns (amount, variability, or fragmentation) overall and by time of day, respectively. Differences in activity patterns by combinations of Aβ and APOE-ε4 status were descriptively examined (n = 105). There were no differences in any activity pattern by Aβ or APOE-ε4 status overall. Aβ+ was associated with lower total amount and lower within-day variability of physical activity overnight and early evening, and APOE-ε4 carriers had higher total amount of activity in the evening and lower within-day variability of activity in the morning. Diurnal curves of activity were blunted among those with Aβ+ regardless of APOE-ε4 status, but only when including older adults with mild cognitive impairment/dementia. Aβ+ in cognitively unimpaired older adults might manifest as lower amount and variability of daily physical activity, particularly during overnight/evening hours. Future research is needed to examine changes in activity patterns in larger samples and by other AD biomarkers.